SUONO BIO, INC.

Profile

Company Names

SUONO BIO, INC.

Addresses

200 FOXBOROUGH BLVD, SUITE 100, FOXBOROUGH, MA 02035

501 MASSACHUSETTS AVENUE, CAMBRIDGE, MA 02139

27 WOLCOTT PARK, MEDFORD, MA 02155

Phone Numbers

617-299-1496
310-382-6475

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2016

State Incorporated:

DELAWARE

Total Amount Raised:

$13,976,840.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2023-08-25 
$500,000.00 
$3,000,000.00 
$2,500,000.00 
Debt 
2
2021-03-19 
$12,176,840.00 
$15,237,250.00 
$3,060,410.00 
Equity 
1
2017-06-20 
$1,300,000.00 
$2,000,000.00 
$700,000.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
SCOTT 
 
KELLOGG 
DIRECTOR, EXECUTIVE OFFICER
ROBERT 
 
LANGER 
DIRECTOR
MICROCHIPS, INC.   |  ARSENAL MEDICAL, INC.   |  ALSERES PHARMACEUTICALS INC /DE   |  ECHO THERAPEUTICS, INC.   |  MICELL TECHNOLOGIES INC   |  CERULEAN PHARMA INC.   |  HUMACYTE INC   |  COMBINENT BIOMEDICAL SYSTEMS, INC.   |  TARIS BIOMEDICAL INC   |  KALA PHARMACEUTICALS, INC.   |  FIBROCELL SCIENCE, INC.   |  PREDICTIVE BIOSCIENCES, INC   |  SEVENTH SENSE BIOSYSTEMS, INC.   |  T2 BIOSYSTEMS, INC.   |  SEMPRUS BIOSCIENCES CORP   |  LIQUIDX, INC.   |  ARSENAL VASCULAR, INC.   |  ARSENAL MEDICAL, INC.   |  SELECTA BIOSCIENCES INC   |  STEMNION, INC.   |  480 BIOMEDICAL, INC.   |  LIVING PROOF INC   |  DX BIOSCIENCES, INC.   |  MODERNA LLC   |  HUMACYTE, INC   |  XTUIT PHARMACEUTICALS, INC.   |  SQZ BIOTECHNOLOGIES CO   |  NOVEOME BIOTHERAPEUTICS, INC.   |  LYNDRA, INC.   |  MODERNA THERAPEUTICS, INC.   |  VERSEAU THERAPEUTICS, INC.   |  FREQUENCY THERAPEUTICS, INC.   |  SUONO BIO, INC.   |  COMBINED THERAPEUTICS, INC.   |  HUMACYTE, INC.   |  SEER BIOSCIENCES, INC.   |  LANDSDOWNE LABS, LLC   |  LIKEMINDS, INC./DE   |  TARVEDA THERAPEUTICS, INC.   |  LUMINOPIA, INC.   |  LYRA THERAPEUTICS, INC.   |  ABPRO CORP   |  GLYMPSE BIO, INC.   |  EPIBONE, INC.   |  TEAL BIO, INC.   |  ZWI THERAPEUTICS, INC.   |  LYNDRA THERAPEUTICS, INC.   |  KENDALL CAPITAL PARTNERS I, L.P.   |  BILAYER THERAPEUTICS, INC.   |  XENTER, INC.   |  VIVTEX CORP   |  SYNTIS BIO, INC.   |  OMNIPULSE BIOSCIENCES, INC.
CARL 
 
SCHOELLHAMMER 
EXECUTIVE OFFICER, DIRECTOR
FREDERICK 
 
SHANE 
DIRECTOR
GIOVANNI 
 
TRAVERSO 
DIRECTOR
VICTORIA 
 
WANG 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2023-08-25 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-03-19 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-03-19 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2017-06-20 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#